Related Experiment Video
Updated: Jun 27, 2025
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Association Between Neuroinflammation and Parkinson's Disease: A Comprehensive Mendelian Randomization Study
YiNi Wang1, XinYu Shi1, YaPing Yin1
1Department of Hygienic Toxicology, School of Public Health, Harbin Medical University, 157 Baojian Road, NanGang District, Harbin, 150081, Heilongjiang Province, People's Republic of China.
Abstract:
The objective of the study is to determine the causal relationship and potential mechanisms between Parkinson's disease (PD) and neuroinflammatory and neurotoxic mediators. We conducted two-sample Mendelian randomization (2SMR) study and multivariable Mendelian randomization (MVMR) analysis to investigate the causality between PD and neuroinflammatory and neurotoxic mediators. The mediation analysis with MR was also conducted to determine the potential mediating effect of neuroinflammatory and neurotoxic mediators between asthma and PD. Genetically predicted levels of nine neuroinflammation were associated with changes in PD risk. The associations of PD with CCL24, galectin-3 levels, haptoglobin, and Holo-Transcobalamin-2 remained significant in multivariable analyses. The mediation analysis with MR revealed that asthma affects PD through CCL24 and galectin-3. The results showed neuroinflammation could affect the pathogenesis of PD. In the combined analysis of these nine variables, CCL24, galectin-3 levels, HP, and Holo-Transcobalamin-2 alone were found to be significant. Asthma plays an intermediary role through CCL24 and galectin-3 levels.
Insights
Neuroinflammation significantly impacts Parkinson's disease (PD) risk, with specific mediators like CCL24 and galectin-3 playing key roles. Asthma may influence PD development through these neuroinflammatory pathways.
Area of Science:
- Neuroscience
- Genetics
- Epidemiology
Background:
- Parkinson's disease (PD) pathogenesis is complex, involving genetic and environmental factors.
- Neuroinflammation and neurotoxic mediators are implicated in neurodegenerative diseases.
- The specific role of neuroinflammatory mediators in PD etiology requires further elucidation.
Purpose of the Study:
- To investigate the causal relationship between Parkinson's disease (PD) and various neuroinflammatory and neurotoxic mediators.
- To explore potential mediating mechanisms, including the role of asthma, in the association between PD and these mediators.
- To identify specific neuroinflammatory markers causally linked to PD risk.
Main Methods:
- Two-sample Mendelian randomization (2SMR) and multivariable Mendelian randomization (MVMR) analyses were employed.
- Mediation analysis using Mendelian randomization (MR) was conducted to assess indirect effects.
- Genetic variants were used as instrumental variables to infer causality.
Main Results:
- Genetically predicted levels of nine neuroinflammatory mediators showed associations with PD risk.
- Significant associations between PD and CCL24, galectin-3, haptoglobin, and Holo-Transcobalamin-2 persisted in multivariable analyses.
- Asthma was found to mediate the effect of PD through CCL24 and galectin-3 levels.
Conclusions:
- Neuroinflammation plays a significant role in the pathogenesis of Parkinson's disease.
- Specific mediators, including CCL24 and galectin-3, are causally linked to PD.
- Asthma acts as an intermediary factor in PD development via these neuroinflammatory pathways.
Related Concept Videos
01:37Neural Regulation
01:15Parkinson's Disease: Overview
01:24Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...